APYX Apyx Medical Corp
Price (delayed)
$1.07
Market cap
$37.07M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.82
Enterprise value
$43.09M
Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people's lives through innovative products in the cosmetic and surgical markets. Known for its innovative Helium
Highlights
The quick ratio has surged by 164% year-on-year but it has declined by 9% since the previous quarter
The revenue is up by 3.4% year-on-year but it has declined by 2.8% since the previous quarter
APYX's debt has soared by 169% YoY
APYX's net income has dropped by 74% year-on-year and by 24% since the previous quarter
Key stats
What are the main financial stats of APYX
Market
Valuations
Earnings
Shares outstanding
34.64M
Market cap
$37.07M
Enterprise value
$43.09M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.51
Price to sales (P/S)
0.76
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.88
Revenue
$49.03M
EBIT
-$23.97M
EBITDA
-$23.19M
Free cash flow
-$9.78M
Per share
Balance sheet
Liquidity
EPS
-$0.82
Free cash flow per share
-$0.28
Book value per share
$0.43
Revenue per share
$1.42
TBVPS
$1.89
Total assets
$65.39M
Total liabilities
$50.47M
Debt
$38.7M
Equity
$14.75M
Working capital
$46.03M
Debt to equity
2.62
Current ratio
5.33
Quick ratio
4.27
Net debt/EBITDA
-0.26
Margins
Efficiency
Dividend
EBITDA margin
-47.3%
Gross margin
61.9%
Net margin
-57.9%
Operating margin
-46%
Return on assets
-41.3%
Return on equity
-119.4%
Return on invested capital
-42.6%
Return on capital employed
-43.8%
Return on sales
-48.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
APYX stock price
How has the Apyx Medical stock price performed over time
Intraday
-7.76%
1 week
-14.4%
1 month
-20.74%
1 year
-72.63%
YTD
-59.16%
QTD
-20.15%
Financial performance
How have Apyx Medical's revenue and profit performed over time
Revenue
$49.03M
Gross profit
$30.35M
Operating income
-$22.58M
Net income
-$28.37M
Gross margin
61.9%
Net margin
-57.9%
APYX's net income has dropped by 74% year-on-year and by 24% since the previous quarter
APYX's net margin has shrunk by 69% YoY and by 28% QoQ
Apyx Medical's operating margin has decreased by 11% QoQ and by 2.7% YoY
APYX's operating income is down by 8% since the previous quarter and by 6% year-on-year
Growth
What is Apyx Medical's growth rate over time
Valuation
What is Apyx Medical stock price valuation
P/E
N/A
P/B
2.51
P/S
0.76
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.88
The EPS has dropped by 74% year-on-year and by 24% since the previous quarter
APYX's equity has dropped by 60% year-on-year and by 27% since the previous quarter
The price to book (P/B) is 33% lower than the 5-year quarterly average of 4.1 and 12% lower than the last 4 quarters average of 3.1
The stock's price to sales (P/S) is 85% less than its 5-year quarterly average of 5.6 and 45% less than its last 4 quarters average of 1.5
The revenue is up by 3.4% year-on-year but it has declined by 2.8% since the previous quarter
Efficiency
How efficient is Apyx Medical business performance
Apyx Medical's return on equity has shrunk by 179% YoY and by 53% QoQ
The company's return on assets fell by 43% YoY and by 23% QoQ
The return on sales has declined by 33% year-on-year and by 28% since the previous quarter
The return on invested capital is up by 20% year-on-year but it has declined by 12% since the previous quarter
Dividends
What is APYX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for APYX.
Financial health
How did Apyx Medical financials performed over time
The total assets is 30% more than the total liabilities
The quick ratio has surged by 164% year-on-year but it has declined by 9% since the previous quarter
Apyx Medical's total liabilities has surged by 96% YoY
APYX's debt is 162% higher than its equity
APYX's debt has soared by 169% YoY
APYX's equity has dropped by 60% year-on-year and by 27% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.